Rob Lambkin‐Williams

6.7k citations
74 papers · 4.6k · 1 hit paper · h-index 31

Impact in

  • Epidemiology top 0.5%
    • Influenza Virus Research Studies
    • Respiratory viral infections research
    • Pneumonia and Respiratory Infections
  • Infectious Diseases top 1%
    • Viral gastroenteritis research and epidemiology
    • SARS-CoV-2 and COVID-19 Research

Papers in

  • Epidemiology 65
    • Influenza Virus Research Studies 48
    • Respiratory viral infections research 34
  • Infectious Diseases 24
    • Viral gastroenteritis research and epidemiology 8
    • SARS-CoV-2 and COVID-19 Research 7
    • Viral Infections and Outbreaks Research 4
Co-authors
John Oxford (35 shared papers)Tom Wilkinson (7 shared papers)Anthony Gilbert (16 shared papers)John P. DeVincenzo (10 shared papers)Andrew J. McMichael (2 shared papers)Cecilia Chui (2 shared papers)Xiao-Ning Xu (2 shared papers)Shobana Balasingam (7 shared papers)
Journals
Vaccine (10 papers)PLoS ONE (6 papers)The Journal of Infectious Diseases (4 papers)Antiviral chemistry & chemotherapy (4 papers)Influenza and Other Respiratory Viruses (3 papers)
Partner nations
United KingdomUnited StatesNetherlands

In The Last Decade

Rob Lambkin‐Williams

74 papers receiving 4.4k citations

Rob Lambkin‐Williams's Hit Papers

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans 2012 · 774 citations
7740+4+9Years since publication250500750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2012 Nature Medicine

Peers

Rob Lambkin‐Williams
Comparison fields: 5 of 132
  • Epidemiology 2.9k
  • Infectious Diseases 1.2k
  • Immunology 967
  • Modeling and Simulation 115
  • Agronomy and Crop Science 195
Replace Larisa V. Gubareva with:
Larisa V. Gubareva United States
John C. Kash United States
Do Quang Ha Vietnam
Julie McAuley Australia
Larisa V. Gubareva United States
John Oxford United Kingdom
Angie Lackenby United Kingdom
Vo Minh Hien Vietnam
Phan Tu Qui Vietnam
Norio Sugaya Japan
Rob Lambkin‐Williams relative to Larisa V. Gubareva United States Larisa V. Gubareva's profile →
Citations per field
00.5×1.5×2.2×
Larisa V. Gubareva · 1×
Citations per year

Countries citing papers authored by Rob Lambkin‐Williams

Since Specialization
Citations

This map shows the geographic impact of Rob Lambkin‐Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Lambkin‐Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Lambkin‐Williams more than expected).

Fields of papers citing papers by Rob Lambkin‐Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Lambkin‐Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Lambkin‐Williams. The network helps show where Rob Lambkin‐Williams may publish in the future.

Co-authors

The 25 scholars most cited alongside Rob Lambkin‐Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rob Lambkin‐Williams Line = papers co-authored together Rob Lambkin‐Williams links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
Nature Medicine ·Tom Wilkinson, Chris Ka‐fai Li, Cecilia Chui, (unknown), Molly Perkins, Julia C. Liebner, Rob Lambkin‐Williams, Anthony Gilbert, John Oxford, Ben Nicholas, Karl J. Staples, Tao Dong, Daniel C. Douek, Andrew J. McMichael, Xiao-Ning Xu
Hit paper breakdown →		2012774
2
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
Proceedings of the National Academy of Sciences ·John P. DeVincenzo, Rob Lambkin‐Williams, Tom Wilkinson, Jeffrey Cehelsky, Sara Nochur, Edward E. Walsh, Rachel Meyers, Jared Gollob, Akshay Vaishnaw
2010342
3
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
Antiviral Research ·J. Ives, Jackie Carr, Dirk B. Mendel, C. Y. Tai, Rob Lambkin‐Williams, Lauren E. Kelly, John Oxford, Frederick G. Hayden, N. A. Roberts
2002301
4
Gene Expression Signatures Diagnose Influenza and Other Symptomatic Respiratory Viral Infections in Humans
Cell Host & Microbe ·Aimee K. Zaas, Minhua Chen, Jay B. Varkey, Timothy Veldman, Alfred O. Hero, Joseph E. Lucas, Yongsheng Huang, Ronald B. Turner, Anthony Gilbert, Rob Lambkin‐Williams, Nancee L. Oien, Bradly P. Nicholson, Stephen F. Kingsmore, Lawrence Carin, Christopher W. Woods, Geoffrey S. Ginsburg
2009282
5
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
New England Journal of Medicine ·John P. DeVincenzo, Richard J. Whitley, Richard L. Mackman, Cecilia Scaglioni-Weinlich, Lisa Harrison, Eric Farrell, Stephen McBride, Rob Lambkin‐Williams, Robert Jordan, Yan Xin, Srini Ramanathan, Thomas G. O’Riordan, Sandra A. Lewis, Xiaoming Li, Seth Toback, Shao‐Lee Lin, Jason W. Chien
2014257
6
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
American Journal of Respiratory and Critical Care Medicine ·John P. DeVincenzo, Tom Wilkinson, Akshay Vaishnaw, Jeff Cehelsky, Rachel Meyers, Saraswathy V. Nochur, Lisa M. Harrison, Patricia Meeking, Alex Mann, Elizabeth Moane, John Oxford, Rajat Pareek, R D Moore, E. T. Walsh, Robert Studholme, Preston H. Dorsett, Rene Alvarez, Rob Lambkin‐Williams
2010239
7
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors
Clinical Microbiology and Infection ·John Oxford, S. Bossuyt, Shobana Balasingam, Anita Mann, Patricia Novelli, Rob Lambkin‐Williams
2003211
8
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
New England Journal of Medicine ·John P. DeVincenzo, Matthew W. McClure, Julian Symons, Hosnieh Fathi, Christopher Westland, Sushmita Chanda, Rob Lambkin‐Williams, Patrick F. Smith, Qingling Zhang, Leo Beigelman, Lawrence M. Blatt, John Fry
2015167
9
Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo
Antiviral Research ·Jackie Carr, J. Ives, Lauren E. Kelly, Rob Lambkin‐Williams, Julia Thom Oxford, Dirk B. Mendel, Lingyu Tai, N. A. Roberts
2002154
10
A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2
PLoS ONE ·Christopher W. Woods, Micah T. McClain, Minhua Chen, Aimee K. Zaas, Bradly P. Nicholson, Jay B. Varkey, Timothy Veldman, Stephen F. Kingsmore, Yongsheng Huang, Rob Lambkin‐Williams, Anthony Gilbert, Alfred O. Hero, Elizabeth Ramsburg, Seth W. Glickman, Joseph E. Lucas, Lawrence Carin, Geoffrey S. Ginsburg
2013124
11
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial
Vaccine ·Suzanne Jones, Kirsten Evans, Hilary McElwaine-Johnn, Michaela Sharpe, John Oxford, Rob Lambkin‐Williams, Tim Mant, Andrew Nolan, Maria Zambon, Joanna Ellis, John Beadle, Peter T. Loudon
2009110
12
Associations between Human Leukocyte Antigens and Nonresponsiveness to Influenza Vaccine
The Journal of Infectious Diseases ·Colin Gelder, Rob Lambkin‐Williams, Keith Hart, Douglas Fleming, O. Martin Williams, Mike Bunce, Kenneth I. Welsh, Sara E. Marshall, John Oxford
200291
13
Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification
Journal of Virology ·Ashley Sobel Leonard, Micah T. McClain, Gavin J. D. Smith, David E. Wentworth, Rebecca Halpin, Xudong Lin, Amy Ransier, Timothy B. Stockwell, Suman R. Das, (unknown), Rob Lambkin‐Williams, Geoffrey S. Ginsburg, Christopher W. Woods, Katia Koelle
201678
14
A hypothesis: the conjunction of soldiers, gas, pigs, ducks, geese and horses in Northern France during the Great War provided the conditions for the emergence of the “Spanish” influenza pandemic of 1918–1919
Vaccine ·John Oxford, Rob Lambkin‐Williams, A. Sefton, R. S. Daniels, Alex J. Elliot, Richard G. Brown, Débora Gil
200471
15
Animal models in influenza vaccine testing
Expert Review of Vaccines ·Jan Willem van der Laan, Carla Herberts, Rob Lambkin‐Williams, Alison Boyers, Alex Mann, John Oxford
200871
16
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
The Journal of Infectious Diseases ·Jerald Sadoff, Els De Paepe, John P. DeVincenzo, Efi Gymnopoulou, Joris Menten, Bryan Murray, Arangassery Rosemary Bastian, An Vandebosch, Wouter Haazen, Nicolas Noulin, Christy Comeaux, Esther Heijnen, Kingsley Eze, Anthony Gilbert, Rob Lambkin‐Williams, Hanneke Schuitemaker, Benoît Callendret
202168
17
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model
Antimicrobial Agents and Chemotherapy ·Jacqueline McBride, Jeremy J. Lim, Tracy Burgess, Rong Deng, Michael A. Derby, Mauricio Maia, Priscilla Horn, Omer Siddiqui, Daniel Sheinson, Haiyin Chen‐Harris, Elizabeth M. Newton, Dimitri Fillos, Denise Nazzal, Carrie M. Rosenberger, Maikke B. Ohlson, Rob Lambkin‐Williams, Hosnieh Fathi, Jeffrey M. Harris, Jorge A. Tavel
201762
18
A plant‐produced influenza subunit vaccine protects ferrets against virus challenge
Influenza and Other Respiratory Viruses ·Vadim Mett, Konstantin Musiychuk, Hong Bi, Christine E. Farrance, April Horsey, Natalia Ugulava, Yôko Shôji, Patricia de la Rosa, Gene A. Palmer, Shailaja Rabindran, Stephen J. Streatfield, Alison Boyers, Michael W. Russell, Alex Mann, Rob Lambkin‐Williams, John Oxford, G. C. Schild, Vidadi Yusibov
200862
19
Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift
Journal of General Virology ·Rob Lambkin‐Williams, Lesley McLain, Shane Jones, S. L. Aldridge, Nigel J. Dimmock
199459
20
Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections
Journal of Clinical Virology ·Micah T. McClain, Lawrence P. Park, Bradly P. Nicholson, Timothy Veldman, Aimee K. Zaas, R. Jay Turner, Rob Lambkin‐Williams, (unknown), Geoffrey S. Ginsburg, Christopher W. Woods
201357

About Rob Lambkin‐Williams

Rob Lambkin‐Williams is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 4.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (48 papers), Respiratory viral infections research (34 papers), Viral gastroenteritis research and epidemiology (8 papers), Immune Response and Inflammation (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Immune Cell Function and Interaction (6 papers), Viral Infections and Outbreaks Research (4 papers) and COVID-19 epidemiological studies (3 papers). The work is most often cited by research in Epidemiology (2.9k citations), Infectious Diseases (1.2k citations), Immunology (967 citations), Modeling and Simulation (115 citations) and Agronomy and Crop Science (195 citations). Rob Lambkin‐Williams has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include John Oxford, Tom Wilkinson, Anthony Gilbert, John P. DeVincenzo, Andrew J. McMichael, Cecilia Chui, Xiao-Ning Xu, Shobana Balasingam, N. A. Roberts and Dirk B. Mendel. Their work appears in journals such as Vaccine, PLoS ONE, The Journal of Infectious Diseases, Antiviral chemistry & chemotherapy and Influenza and Other Respiratory Viruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larisa V. GubarevaBreakdown of academic impact, for papers by John C. KashBreakdown of academic impact, for papers by Do Quang HaBreakdown of academic impact, for papers by Julie McAuleyBreakdown of academic impact, for papers by Larisa V. GubarevaBreakdown of academic impact, for papers by John OxfordBreakdown of academic impact, for papers by Angie LackenbyBreakdown of academic impact, for papers by Vo Minh HienBreakdown of academic impact, for papers by Phan Tu QuiBreakdown of academic impact, for papers by Norio Sugaya